D-886-2013 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- August 21, 2013
- Initiation Date
- February 26, 2013
- Termination Date
- June 6, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 998 Bottles
Product Description
Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887
Reason for Recall
Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.
Distribution Pattern
Canada
Code Information
Lot # 3099036, Exp 03/2014